Ocuphire Pharma Inc. buy BiotechBee
Start price
03.01.23
/
60%
€3.31
Target price
31.03.25
€5.00
Performance (%)
-3.24%
End price
10.01.23
€3.20
Summary
This prediction ended on 10.01.23 with a price of €3.20. With a performance of -3.24%, the BUY prediction for Ocuphire Pharma Inc. by BiotechBee closed slightly in the red. BiotechBee has a follow-up prediction for Ocuphire Pharma Inc. where he still thinks Ocuphire Pharma Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocuphire Pharma Inc. | 20.810% | 20.810% | -66.078% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% |
According to BiotechBee what are the pros and cons of Ocuphire Pharma Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
In the thread Trading Ocuphire Pharma Inc.
Current prediction by BiotechBee for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.71
03.09.23
03.09.23
€5.00
30.11.25
30.11.25
-53.31%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.20
10.01.23
10.01.23
€6.00
31.12.25
31.12.25
-28.13%
26.01.23
26.01.23
Could be very worthwhile Investment >20% year